Penelope Kokkinides Plan for Improving Puerto Rico’s Healthcare

Penelope Kokkinides is the Chief Administration Officer of Innovacare. This company is a major healthcare service provider to the people of Puerto Rico. Kokkinides is second in command of the organization which is headed by Rick Shinto. In April of 2018, CAO Kokkinides met with President Trump to discuss the healthcare issues in Puerto Rico. She was a part of a panel of 8 women who held a meeting with the president to discuss healthcare problems within the U.S. and in Puerto Rico.

 

Kokkinides told the president about a plan that she believed would work to correct Puerto Rico’s healthcare dilemma. She informed the president that the best way to improve Puerto Rico’s healthcare situation is to improve the financial spending that has been cut by the government since 2011.

 

The main problem with Puerto Rico’s healthcare system is that the government is not adequately funding the system on the island. Improving the financial cuts will allow more people to receive basic healthcare. They will be able to afford to pay for it. Kokkinides is a knowledgeable figure in the field of healthcare. This lady has many years of experience working in leadership roles within this industry. She also understands how to set up healthcare infrastructure that will be beneficial to the government and to people who need it the most. Kokkinides has insight into healthcare and can quickly come up with solutions that will help to improve the health aspect of people’s lives.

 

Rick Shinto and Kokkinides realized that setting up temporary medical facilities is also one of the best ways to improve the current healthcare situation in Puerto Rico. When Hurricane Maria struck the island on September 16, 2017; the territory was devastated. Many hospitals had been destroyed and never recovered. The healthcare clinics offered by Innovacare has provided basic health services to thousands of people who might no be able to have any healthcare at all.

 

Puerto Rico’s healthcare situation will not be an easy fix. The island’s economic situation has been a main catalyst for the problems that it has faced. Hurricane Maria simply made the situation much worse than it already is. Thankfully, the people of Puerto Rico has an insightful and knowledgeable person such as Kokkinides who can help to change this situation around.

 

The Amazing Career of the Legendary Investor and Researcher, Scott Rocklage

Scott M. Rocklage is a living legend having worked with over ten publicly-traded pharmaceutical firms to date. Prof. Rocklage joined 5AM Venture firm quickly working his way to be named as a managing partner at 5AM Ventures barely a year later in 2004.

Scott will forever go down in history as a giant, especially bearing in mind that he has secured well over 25 U.S patents so far.

MIT Encounters

Interestingly, Scott rubbed shoulders with the eminent scientist and the Chemistry Nobel Prize winner, Richard R. Schrock during his MIT days. The seasoned researcher and investor completed two Chemistry degrees at MIT and at UCLA Berkley.

Scott Rocklage is a vastly decorated drug development researcher with a record tally of over 100 peer-reviewed medical journals published.

Running 5AM Ventures

Dr. Rocklage spends most of his day running 5AM Ventures from their headquarters in Boston, MA. 5AM specializes is a startup incubator company designed to assist the young, broke and inexperienced entrepreneurs as they build their ideas and concepts.

For three decades, Scott took on the important positions of President, CEO, and Chairman in a barrage of successful pharmaceutical firms in the States. Here are the NASDAQ and Dow Jones Traded Companies he’s led and his positions:-

  • CEO and Chairman of Cubist Pharmaceuticals
  • Chairman at Relypsa and Novira Inc.
  • Chairperson of Kinestral, Cidara and Rennovia Inc.
  • Executive Chairman at Semprus, Miikana, and Ilypsa
  • Previous Companies Served

Dr. Scott Rocklage is a shrewd investor renowned for his capital raising prowess. Over the course of his career, he’s succeeded to raise hundreds of millions of seed money to fund vital departments in the pharmaceutical firms he served. Read more: Scott Rocklage | Crunchbase and Scott Racklage | Bloomberg

As the Chairman of Pulmatrix Inc., he managed to breathe new life into the firm’s R&D department by raising an estimated $10M. In 2012, the brilliant investor repeated the same by helping Novira Inc. raise $23M in finances. Last year, Scott Rocklage oversaw the negotiations that led to Aprea AB Inc. to get $51M from investors.

Interview Recap

Dr. Rocklage has devoted personal resources and energy to chase down viable cancer cures.

No wonder, he stated that he’s overly excited by how new technology is aiding researchers in their quest for the ever-elusive cancer treatment and cure. Click here to read the rest of the captivating interview Dr. Scott did with Ideasmensch.com